Clinical Trial

Autologous Serum Eye Drops in Dry Eye Syndrome

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated December 22, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study aims to evaluate the clinical efficacy and safety of autologous serum eye drops (ASEDs) in patients with moderate-to-severe dry eye syndrome who are refractory to conventional artificial tear therapy.
Trial Details
NCT Number NCT07295691
Lead Sponsor The General Authority for Teaching Hospitals and Institutes
Conditions Autologous Serum Eye Drops, Dry Eye Syndrome
Enrollment 70 participants
Start Date 2025-09-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-12-22